Thomas Jonassen
Chief Tech/Sci/R&D Officer chez SYNACT PHARMA AB
Provenance du réseau au premier degré de Thomas Jonassen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
University of Copenhagen
36
| College/University | Other Consumer Services | 36 |
ResoTher Pharma AS
 ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors.
6
| Private Company | Pharmaceuticals: Major | 6 |
| Public Company | Pharmaceuticals: Major | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Thomas Jonassen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
| CHEMOMETEC A/S | Medical Specialties | Chief Executive Officer Director/Board Member | |
The Carlsbergfondet Foundation
 The Carlsbergfondet Foundation Financial ConglomeratesFinance Carlsbergfondet Foundation engages in the financing and promotion of art and art sciences. The company was founded by J. C. Jacobsen in 1876 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chairman Director/Board Member | |
| COLOPLAST A/S | Medical Specialties | Chairman Chief Tech/Sci/R&D Officer | |
| CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Chairman Corporate Officer/Principal Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Cheminova A/S
 Cheminova A/S Chemicals: AgriculturalProcess Industries Cheminova A/S manufactures pesticides and other agrochemical products. It offers herbicides, insecticides, fungicides, seed dressings, regulants, grain protectants, and animal health products. The company was founded by Gunnar Andreasen in 1938 and is headquartered in Harboøre, Denma rk. | Chemicals: Agricultural | Chairman Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Graduate Degree Masters Business Admin | |
| University of Aarhus | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman Chairman | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| University of Lund | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| University of Southern Denmark | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SOLAR A/S | Engineering & Construction | Director/Board Member Chairman | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| BONESUPPORT HOLDING AB | Medical Specialties | Director of Finance/CFO Founder | |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member | |
Getinge Cetrea A/S
 Getinge Cetrea A/S Packaged SoftwareTechnology Services Getinge Cetrea A/S develops clinical logistics and communication software products. Its products include insight enterprise, insight emergency, insight surgical, insight ICU and insight patient ward. The company was founded by Kakob E. Bardram in 2006 and is headquartered in Aarhus Nord, Denmark. | Packaged Software | Founder | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Founder Corporate Officer/Principal | |
| Danish National Research Foundation | Corporate Officer/Principal Founder | ||
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chairman Director of Finance/CFO Chief Executive Officer | |
| Alfred Benzon Foundation | Director/Board Member Corporate Officer/Principal | ||
Confederation of Danish Industry
 Confederation of Danish Industry Miscellaneous Commercial ServicesCommercial Services Confederation of Danish Industry operates as a business and employers organization for small and medium-sized enterprises. It serves manufacturing industry as well as sectors such as transportation, energy, information technology, health, trade, and professional services. The firm specializes in negotiation of collective agreements with labor unions; local, national, and international business regulations; and support for members on numerous services and relevant networks. The company is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| Timpco ApS | Chief Executive Officer | ||
| European Organisation for Research & Treatment of Cancer | Director/Board Member | ||
| Copenhagen University Hospital | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Royal Danish Academy of Sciences & Letters | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
Danish Cancer Society
 Danish Cancer Society Miscellaneous Commercial ServicesCommercial Services The Danish Cancer Society provides support and resources for those affected by cancer, including patients and their families. The non-profit company is based in Copenhagen, Denmark and has subsidiaries in Denmark. The Danish company offers the latest information on patient involvement in cancer treatment and tools for utilizing patient-reported information. The organization also promotes cancer prevention through screening and works towards reducing the number of cancer cases and improving the quality of life for those who have survived cancer. | Miscellaneous Commercial Services | Corporate Officer/Principal President | |
Renovaro Biosciences Denmark ApS
 Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Sino Danish Breast Cancer Research Centre | Director/Board Member | ||
BONE SUPPORT AB
 BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Director of Finance/CFO Founder | |
| 2CUREX AB | Medical Specialties | Founder Director/Board Member | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Founder Chief Executive Officer Founder | |
Gibson Oncology LLC
 Gibson Oncology LLC BiotechnologyHealth Technology Gibson Oncology LLC composes proven academic researchers and bio tech entrepreneurs. The firm also develops novel oncology drugs to treat resistant cancers with a focus on children. The company was founded by Mark C. Rogers, Theodore C, Solomon, Cliff T. Solomon and Elizabeth L. Rogers and is headquartered in Miami, FL. | Biotechnology | Director/Board Member | |
| TXP Pharma GmbH | Chief Executive Officer Founder Corporate Officer/Principal |
Statistiques
Internationale
| Danemark | 40 |
| Suède | 6 |
| Etats-Unis | 5 |
| Belgique | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 9 |
| Miscellaneous | 5 |
| Commercial Services | 5 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 223 |
| Corporate Officer/Principal | 118 |
| Chairman | 73 |
| Founder | 47 |
| Chief Executive Officer | 43 |
Relations les plus connectées
| Insiders | |
|---|---|
| Peter Buhl Jensen | 32 |
| Agnete Raaschou-Nielsen | 32 |
| Jeppe Øvlesen | 27 |
| Lars Åke Alvar Lidgren | 24 |
| Lars Søren Rasmussen | 21 |
| Björn Westberg | 21 |
| Thomas Feldthus | 20 |
| Peter Gæmelke | 19 |
| Lykke Friis | 19 |
| Kirsten Drejer | 18 |
| Nils Aage Brünner | 17 |
| Anders Kronborg | 17 |
| Jakob Bo Thomasen | 14 |
| Jesper Zeuthen | 13 |
| Povl Krogsgaard-Larsen | 12 |
- Bourse
- Insiders
- Thomas Jonassen
- Connexions Sociétés
